Sex Differences in Depression and Anxiety

Overview

Journal Curr Top Behav Neurosci

Publisher Springer

Specialty Psychology

Date 2022 Aug 1

PMID 35915385

Authors

Pavlina Pavlidi

Nikolaos Kokras

Christina Dalla

Affiliations

Soon will be listed here.

Abstract

Depression and anxiety disorders carry a tremendous worldwide burden and emerge as a significant cause of disability among western societies. Both disorders are known to disproportionally affect women, as they are twice more likely to be diagnosed and moreover, they are also prone to suffer from female-specific mood disorders. Importantly, the prevalence of these affective disorders has notably risen after the COVID pandemic, especially in women. In this chapter, we describe factors that are possibly contributing to the expression of such sex differences in depression and anxiety. For this, we overview the effect of transcriptomic and genetic factors, the immune system, neuroendocrine aspects, and cognition. Furthermore, we also provide evidence of sex differences in antidepressant response and their causes. Finally, we emphasize the importance to consider sex as a biological variable in preclinical and clinical research, which may facilitate the discovery and development of new and more efficacious antidepressant and anxiolytic pharmacotherapies for both women and men.

Citing Articles

Sexual assault experience, depression, and heavy substance use among German adults: an exploratory mediation analysis.

Belau M, Wiessner C, Sehner S, Dekker A, Briken P BMC Public Health. 2025; 25(1):935.

PMID: 40065280 PMC: 11892163. DOI: 10.1186/s12889-025-22117-4.

Relieving anxiety and depression symptoms through promoting organizational identity and mitigating family-work conflict among medical professionals in digital leadership.

Zhou X, Yang X, Chen S, Wen Q, Xie F, Zhang S BMC Public Health. 2024; 24(1):3563.

PMID: 39716125 PMC: 11664897. DOI: 10.1186/s12889-024-20992-x.

Prefrontal cortex-nucleus reuniens-hippocampus network exhibits sex-differentiated responses to stress and antidepressant treatment in rats.

Kafetzopoulos V, Kokras N, Katsaitis F, Sousa N, Leite-Almeida H, Sotiropoulos I Psychopharmacology (Berl). 2024; .

PMID: 39162717 DOI: 10.1007/s00213-024-06667-w.

Multiple Sex- and Circuit-Specific Mechanisms Underlie Exercise-Induced Stress Resistance.

Tanner M, Mellert S, Fallon I, Baratta M, Greenwood B Curr Top Behav Neurosci. 2024; 67:37-60.

PMID: 39080242 DOI: 10.1007/7854_2024_490.

The Interaction of Vasopressin with Hormones of the Hypothalamo-Pituitary-Adrenal Axis: The Significance for Therapeutic Strategies in Cardiovascular and Metabolic Diseases.

Szczepanska-Sadowska E, Czarzasta K, Bogacki-Rychlik W, Kowara M Int J Mol Sci. 2024; 25(13).

PMID: 39000501 PMC: 11242374. DOI: 10.3390/ijms25137394.

References

Agid Y, Buzsaki G, Diamond D, Frackowiak R, Giedd J, Girault J . How can drug discovery for psychiatric disorders be improved?. Nat Rev Drug Discov. 2007; 6(3):189-201. DOI: 10.1038/nrd2217. View

Alexander A, Irving A, Harvey J . Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology. 2016; 113(Pt B):652-660. DOI: 10.1016/j.neuropharm.2016.07.003. View

Altemus M, Sarvaiya N, Epperson C . Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014; 35(3):320-30. PMC: 4890708. DOI: 10.1016/j.yfrne.2014.05.004. View

Amsterdam J, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, Beasley C . Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999; 55(1):11-7. DOI: 10.1016/s0165-0327(98)00203-1. View

Anderson G . Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt). 2005; 14(1):19-29. DOI: 10.1089/jwh.2005.14.19. View

Arevalo M, Azcoitia I, Garcia-Segura L . The neuroprotective actions of oestradiol and oestrogen receptors. Nat Rev Neurosci. 2014; 16(1):17-29. DOI: 10.1038/nrn3856. View

Atkinson H, Waddell B . Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous cycle. Endocrinology. 1997; 138(9):3842-8. DOI: 10.1210/endo.138.9.5395. View

Balta G, Dalla C, Kokras N . Women's Psychiatry. Adv Exp Med Biol. 2019; 1192:225-249. DOI: 10.1007/978-981-32-9721-0_11. View

Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain S . Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry. 2016; 18(3):162-214. PMC: 5341771. DOI: 10.1080/15622975.2016.1190867. View

10.

Bangasser D, Curtis A, Reyes B, Bethea T, Parastatidis I, Ischiropoulos H . Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry. 2010; 15(9):877, 896-904. PMC: 2935505. DOI: 10.1038/mp.2010.66. View

11.

Bangasser D, Reyes B, Piel D, Garachh V, Zhang X, Plona Z . Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol Psychiatry. 2012; 18(2):166-73. PMC: 3402704. DOI: 10.1038/mp.2012.24. View

12.

Berlanga C, Flores-Ramos M . Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. J Affect Disord. 2006; 95(1-3):119-23. DOI: 10.1016/j.jad.2006.04.029. View

13.

Berton O, Nestler E . New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006; 7(2):137-51. DOI: 10.1038/nrn1846. View

14.

Bigos K, Pollock B, Stankevich B, Bies R . Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. Gend Med. 2010; 6(4):522-43. DOI: 10.1016/j.genm.2009.12.004. View

15.

Blanco C, Vesga-Lopez O, Stewart J, Liu S, Grant B, Hasin D . Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2011; 73(2):224-32. PMC: 3475327. DOI: 10.4088/JCP.10m06227. View

16.

Bloch M, Schmidt P, Danaceau M, Murphy J, Nieman L, Rubinow D . Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000; 157(6):924-30. DOI: 10.1176/appi.ajp.157.6.924. View

17.

Bloch M, Daly R, Rubinow D . Endocrine factors in the etiology of postpartum depression. Compr Psychiatry. 2003; 44(3):234-46. DOI: 10.1016/S0010-440X(03)00034-8. View

18.

Bogetto F, Bellino S, Revello R, Patria L . Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs. 2002; 16(4):273-83. DOI: 10.2165/00023210-200216040-00006. View

19.

Bollinger J, Bergeon Burns C, Wellman C . Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex. Brain Behav Immun. 2015; 52:88-97. PMC: 4909118. DOI: 10.1016/j.bbi.2015.10.003. View

20.

Borrow A, Cameron N . Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 54:13-25. DOI: 10.1016/j.pnpbp.2014.05.009. View